 |
 Video: What is a Stock Split?
|
|
|
| ITUS is an early stage biotechnology company. Through its subsidiary, Anixa Diagnostics Corporation, Co. develops a platform for non-invasive blood tests for the early detection of cancer. That platform is called Cchek™. Co.'s CchekO™ cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence, and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. Co. is also engaged in limited patent licensing activities in the area of encrypted audio/video conference calling. According to our ITUS split history records, ITUS has had 1 split. | |
|
ITUS (ITUS) has 1 split in our ITUS split history database. The split for ITUS took place on October 18, 2016.
Looking at the ITUS split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ITUS shares, starting with a $10,000 purchase of ITUS, presented on a split-history-adjusted basis factoring in the complete ITUS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/05/2014 |
|
| End date: |
09/28/2018 |
|
| Start price/share: |
$0.15 |
|
| End price/share: |
$4.64 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
2,993.33% |
|
| Average Annual Total Return: |
145.93% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$309,340.88 |
|
| Years: |
3.81 |
|
|
|
| Date |
Ratio |
| 10/18/2016 | 1 for 1 |
|
|
Free ITUS Email Alerts:
